HeartSciences Inc. HSCS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.50K | 4.30K | 8.70K | 8.70K | 6.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.50K | 4.30K | 8.70K | 8.70K | 6.30K |
| Cost of Revenue | 1.80K | 1.80K | 3.70K | 3.70K | 2.70K |
| Gross Profit | 2.70K | 2.50K | 5.00K | 5.00K | 3.60K |
| SG&A Expenses | 6.73M | 5.58M | 4.51M | 4.56M | 4.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.48M | 8.42M | 7.81M | 8.25M | 8.16M |
| Operating Income | -9.48M | -8.41M | -7.80M | -8.24M | -8.15M |
| Income Before Tax | -10.26M | -9.14M | -8.49M | -9.04M | -8.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.26 | -9.14 | -8.49 | -9.04 | -8.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.26M | -9.14M | -8.49M | -9.04M | -8.77M |
| EBIT | -9.48M | -8.41M | -7.80M | -8.24M | -8.15M |
| EBITDA | -9.45M | -8.39M | -7.77M | -8.21M | -8.12M |
| EPS Basic | -3.21 | -3.93 | -5.01 | -6.95 | -8.37 |
| Normalized Basic EPS | -2.01 | -2.45 | -3.13 | -4.34 | -5.23 |
| EPS Diluted | -3.21 | -3.93 | -5.01 | -6.95 | -8.37 |
| Normalized Diluted EPS | -2.01 | -2.45 | -3.13 | -4.34 | -5.23 |
| Average Basic Shares Outstanding | 12.75M | 10.39M | 8.32M | 6.14M | 4.28M |
| Average Diluted Shares Outstanding | 12.75M | 10.39M | 8.32M | 6.14M | 4.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |